Cited by 1,967Cancer-related Molecular PathwaysCell death mechanisms and regulationPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 168 of the 169 references it cites were found in a registry or an index.

The first 30 years of p53: growing ever more complex.

Open access

Levine, Arnold J., Oren, Moshe·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Thirty years ago p53 was discovered as a cellular partner of simian virus 40 large T-antigen, the oncoprotein of this tumour virus. The first decade of p53 research saw the cloning of p53 DNA and the realization that p53 is not an oncogene but a tumour suppressor that is very frequently mutated in human cancer. In the second decade of research, the function of p53 was uncovered: it is a transcription factor induced by stress, which can promote cell cycle arrest, apoptosis and senescence. In the third decade after its discovery new functions of this protein were revealed, including the regulation of metabolic pathways and cytokines that are required for embryo implantation. The fourth decade of research may see new p53-based drugs to treat cancer. What is next is anybody's guess.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc2723

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“More recently, induction of cellular senescence was identified as an additional mechanism whereby p53 curbs neoplastic processe”
p53, guardian of the genome
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Self-citation
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citation
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765

Show all 169 references

Sorted by citations

Items 501–600 of 1,002

Theabrownin triggers DNA damage to suppress human osteosarcoma U2 OS cells by activating p53 signalling pathway
Jin, W., Zhou, L., Yan, B., Li, Y., Liu, F., Tong, P., Yu, W., Dong, X., Xie, L., Zhang, J., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13742 · Cited by 44
Single-cell transcriptomic analysis uncovers diverse and dynamic senescent cell populations
Wechter, N., Rossi, M., Anerillas, C., Tsitsipatis, D., Piao, Y., Fan, J., Martindale, J. L., De, S., Mazan-Mamczarz, K., & Gorospe, M. (2023) · Aging · doi:10.18632/aging.204666 · Cited by 43
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis
Fisher, O. M., Lord, S. J., Falkenback, D., Clemons, N. J., Eslick, G. D., & Lord, R. V. (2016) · Gut · doi:10.1136/gutjnl-2015-310888 · Cited by 43
Cystatin C as a p53‐inducible apoptotic mediator that regulates cathepsin L activity
Mori, J., Tanikawa, C., Funauchi, Y., Lo, P. H. Y., Nakamura, Y., & Matsuda, K. (2016) · Cancer Science · doi:10.1111/cas.12881 · Cited by 45
Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53
Chao, T., Zhou, X. Y., Cao, B., Liao, P., Liu, H., Chen, Y., Park, H., Zeng, S. X., & Lu, H. (2016) · Nature Communications · doi:10.1038/ncomms13755 · Cited by 43
Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?
Strycharz, J., Drzewoski, J., Szemraj, J., & Śliwińska, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9270549 · Cited by 45
p53 switches off pluripotency on differentiation
Lin, T., & Lin, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0498-1 · Cited by 44
Small interfering RNA–mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma
Hajiasgharzadeh, K., Somi, M. H., Shanehbandi, D., Mokhtarzadeh, A., & Baradaran, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27015 · Cited by 43
Crotonylation at serine 46 impairs p53 activity
Liao, P., Bhattarai, N., Cao, B., Zhou, X. Y., Jung, J. H., Damera, K., Fuselier, T. T., Thareja, S., Wimley, W. C., Wang, B., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.152 · Cited by 43
Plumbagin induces Ishikawa cell cycle arrest, autophagy, and apoptosis via the PI3K/Akt signaling pathway in endometrial cancer
Zhang, X., Kan, H., Liu, Y., & Ding, W. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111957 · Cited by 43
Advances in cancer treatment: a new therapeutic target, Annexin A2
Li, Z., Yu, L., Hu, B., Chen, L., Jv, M., Wang, L., Zhou, C., Wei, M., & Zhao, L. (2021) · Journal of Cancer · doi:10.7150/jca.55173 · Cited by 43
The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review
Bekhet, O. H., & Eid, M. E. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-629 · Cited by 45
Targeting Mdmx to treat breast cancers with wild-type p53
Haupt, S., Buckley, D., Pang, J.-M., Panimaya, J., Paul, P. J., Gamell, C., Takano, E. A., Lee, Y. Y., Hiddingh, S., Rogers, T.-M., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.173 · Cited by 42
Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression
Lushnikova, T., Bouska, A., Odvody, J., Dupont, W. D., & Eischen, C. M. (2011) · Oncogene · doi:10.1038/onc.2011.172 · Cited by 40
Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
Li, X., Gohain, N., Chen, S., Li, Y., Zhao, X., Li, B., Tolbert, W. D., He, W., Pazgier, M., Hu, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.06.010 · Cited by 46
Analysis of senescence-responsive stress fiber proteome reveals reorganization of stress fibers mediated by elongation factor eEF2 in HFF-1 cells
Liu, S., Matsui, T. S., Kang, N. H., & Deguchi, S. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-05-0229 · Cited by 42
Effect of a natural mutation in the 5′ untranslated region on the translational control of p53 mRNA
Khan, D., Sharathchandra, A., Ponnuswamy, A., Grover, R., & Das, S. (2012) · Oncogene · doi:10.1038/onc.2012.422 · Cited by 42
Pontin, a new mutant p53-binding protein, promotes gain-of-function of mutant p53
Zhao, Y., Zhang, C., Yue, X., Li, X., Liu, X. J., Yu, H., Белый, В. А., Yang, Q., Feng, Z., & Hu, W. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.33 · Cited by 42
Spontaneous Single-Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival
Amir, H., Touboul, T., Sabatini, K., Chhabra, D., Garitaonandia, I., Loring, J. F., Morey, R. E., & Laurent, L. C. (2016) · Stem Cells · doi:10.1002/stem.2550 · Cited by 39
NAD+ augmentation ameliorates acute pancreatitis through regulation of inflammasome signalling
Shen, A., Kim, H.-J., Oh, G., Lee, S.-B., Lee, S. H., Pandit, A., Khadka, D., Choe, S., Kwak, S. C., Yang, S. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03418-0 · Cited by 42
TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition
Lima, S., Takabe, K., Newton, J. C., Saurabh, K., Young, M. M., Leopoldino, A. M., Hait, N. C., Roberts, J. L., Wang, H., Dent, P., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1429875 · Cited by 42
Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics
Yu, X., Kogan, S., Chen, Y., Tsang, A. T., Withers, T. A., Lin, H., Gilleran, J., Buckley, B., Moore, D. F., Bertino, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0822 · Cited by 42
Telomerase Reverse Transcriptase and p53 Regulate Mammalian Peripheral Nervous System and CNS Axon Regeneration Downstream of c-Myc
Ma, J., Ju, X., Xu, R., Wang, W.-H., Luo, Z., Liu, C., Yang, L., Li, B., Chen, J., Meng, B., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0419-19.2019 · Cited by 42
IRES mediated translational regulation of p53 isoforms
Arandkar, S., Katoch, A., & Das, S. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1202 · Cited by 50
Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies
Haddadin, L., & Sun, X. S. (2025) · Cells · doi:10.3390/cells14070538 · Cited by 47
p53 Gene Repair with Zinc Finger Nucleases Optimised by Yeast 1-Hybrid and Validated by Solexa Sequencing
Herrmann, F., Garriga-Canut, M., Baumstark, R., Fajardo-Sánchez, E., Cotterell, J., Minoche, A. E., Himmelbauer, H., & Isalan, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020913 · Cited by 41
Linear Aliphatic Dialkynes as Alternative Linkers for Double‐Click Stapling of p53‐Derived Peptides
Lau, Y. H., de Andrade, P., McKenzie, G. J., Venkitaraman, A. R., & Spring, D. R. (2014) · ChemBioChem · doi:10.1002/cbic.201402374 · Cited by 43
Alkaline ceramidase 2 is a novel direct target of p53 and induces autophagy and apoptosis through ROS generation
Wang, Y., Zhang, C., Jin, Y., Wang, He, Q., Liu, Z., Ai, Q., Lei, Y., Li, Y., Song, F., et al. (2017) · Scientific Reports · doi:10.1038/srep44573 · Cited by 41
Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53
Peng, W., Hu, C., Shu, Z., Han, T., Qin, L., & Zheng, C. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.05.003 · Cited by 41
The protective effect of Morin against ifosfamide-induced acute liver injury in rats associated with the inhibition of DNA damage and apoptosis
Özdemir, S., Küçükler, S., Çomaklı, S., & Kandemır, F. M. (2020) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1822390 · Cited by 41
DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications
Sadoughi, F., Dana, P. M., Asemi, Z., & Yousefi, B. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103105 · Cited by 42
Characterization of Functional Domains Necessary for Mutant p53 Gain of Function
Yan, W., & Chen, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.097253 · Cited by 40
Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein
Dong, C., Zhao, B., Long, F., Liu, Y., Liu, Z., Li, S., Yang, X., Sun, D., Wang, H., Liu, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7091 · Cited by 40
Genetically engineered livestock for biomedical models
Rogers, C. S. (2016) · Transgenic Research · doi:10.1007/s11248-016-9928-6 · Cited by 42
Oncolysis by paramyxoviruses: preclinical and clinical studies
Matveeva, O. V., Guo, Z. S., Senin, V. M., Senina, A. V., Shabalina, S. A., & Chumakov, P. M. (2015) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2015.17 · Cited by 41
Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer
Shakya, R., Tarulli, G. A., Sheng, L., Lokman, N. A., Ricciardelli, C., Pishas, K. I., Selinger, C. I., Kohonen‐Corish, M. R. J., Cooper, W. A., Turner, A. G., et al. (2017) · Oncogene · doi:10.1038/onc.2017.66 · Cited by 42
Epigenetics and the dynamics of chromatin during adenovirus infections
Lynch, K. L., Gooding, L. R., Garnett‐Benson, C., Ornelles, D. A., & Avgousti, D. C. (2019) · FEBS Letters · doi:10.1002/1873-3468.13697 · Cited by 40
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
Kohlmeyer, J. L., Gordon, D. J., Tanas, M. R., Monga, V., Dodd, R. D., & Quelle, D. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083018 · Cited by 41
Drosophila melanogaster mitochondrial Hsp22: a role in resistance to oxidative stress, aging and the mitochondrial unfolding protein response
Morrow, G., Pécheur, M. L., & Tanguay, R. M. (2015) · Biogerontology · doi:10.1007/s10522-015-9591-y · Cited by 42
Dysregulated ΔNp63α Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes
Ha, L., Ponnamperuma, R. M., Jay, S., Ricci, M., & Weinberg, W. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021877 · Cited by 42
Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis.
Solomon, H., Brosh, R., Buganim, Y., & Rotter, V. (2010) · PubMed · Cited by 40
Identifying the determinants of response to MDM2 inhibition
Saiki, A. Y., Caenepeel, S. R., Cosgrove, E. J., Su, C., Boedigheimer, M. J., & Oliner, J. D. (2015) · Oncotarget · doi:10.18632/oncotarget.3116 · Cited by 39
Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m6A modification and diverse cell death mechanisms
Wang, X., Yang, J., Yang, W., Sheng, H., Jia, B., Peng, C., Xu, S., Hong, X., Jiang, C., Yang, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.10.026 · Cited by 46
Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts
Kim, T. H., Kim, H. S., Kang, Y. J., Yoon, S., Lee, J., Choi, W. S., Jung, J. H., & Kim, H. S. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.007 · Cited by 39
Dominant negative (ΔN) p63α induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways
Mundt, H. M., Stremmel, W., Melino, G., Krammer, P. H., Schilling, T., & Müller, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.093 · Cited by 39
The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
Orzol, P., Holčáková, J., Nekulová, M., Nenutil, R., Vojtěšek, B., & Coates, P. J. (2015) · PubMed · doi:10.14670/hh-30.503 · Cited by 39
Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
Pen, J. L., Laurent, M., Sarosiek, K. A., Vuillier, C., Gautier, F., Montessuit, S., Martinou, J., Letai, A. G., Braun, F., & Juin, P. P. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.400 · Cited by 40
Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p
Wan, Y., Shen, A., Qi, F., Chu, J., Cai, Q., Sferra, T. J., Peng, J., & Chen, Y. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4972 · Cited by 40
Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy
Ridinger-Saison, M., DelGiorno, K. E., Zhang, T., Kraus, A., French, R. P., Jaquish, D., Tsui, C., Erikson, G. A., Spike, B. T., Shokhirev, M. N., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189051 · Cited by 40
The long non-coding RNA AK001796 contributes to tumor growth via regulating expression of p53 in esophageal squamous cell carcinoma
Liu, B., Pan, C., Yao, G., Wei, K., Xia, Y., & Chen, Y. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0537-8 · Cited by 39
A potential link between p53, cell competition and ribosomopathy in mammals and in Drosophila
Baker, N. E., Kiparaki, M., & Khan, C. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.11.018 · Cited by 39
The PTTG1-Binding Factor (PBF/PTTG1IP) Regulates p53 Activity in Thyroid Cells
Read, M. L., Seed, R., Fong, J. C., Modasia, B., Ryan, G. A., Watkins, R. J., Gagliano, T., Smith, V. E., Stratford, A. L., Kwan, P., et al. (2014) · Endocrinology · doi:10.1210/en.2013-1646 · Cited by 39
USP7S-dependent inactivation of Mule regulates DNA damage signalling and repair
Khoronenkova, S. V., & Dianov, G. L. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1359 · Cited by 39
Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells
Wang, L., Zhao, Y., Wu, Q., Guan, Y., & Wu, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8455 · Cited by 39
Synthesizing a Genetic Sensor Based on CRISPR-Cas9 for Specifically Killing p53-Deficient Cancer Cells
Zhan, H., Xie, H., Zhou, Q., Liu, Y., & Huang, W. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00202 · Cited by 36
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics
Lion, M., Bisio, A., Tebaldi, T., Sanctis, V. D., Menéndez, D., Resnick, M. A., Ciribilli, Y., & Inga, A. (2013) · Cell Cycle · doi:10.4161/cc.24309 · Cited by 39
Combined Effect of Genetic Polymorphisms in P53, P73, and MDM2 on Non-small Cell Lung Cancer Survival
Liu, L., Wu, C. H., Wang, Y., Zhong, R., Duan, S., Wei, S., Lin, S., Zhang, X., Tan, W., Yu, D., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182272273 · Cited by 38
Structural Plasticity of Methyllysine Recognition by the Tandem Tudor Domain of 53BP1
Tong, Q., Cui, G., Botuyan, M. V., Rothbart, S. B., Hayashi, R., Musselman, C. A., Singh, N., Appella, E., Strahl, B. D., Mer, G., et al. (2015) · Structure · doi:10.1016/j.str.2014.11.013 · Cited by 39
Coordinating Gene Expression and Axon Assembly to Control Axon Growth: Potential Role of GSK3 Signaling
Liu, C.-M., Hur, E., & Zhou, F. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00003 · Cited by 41
MRPL35 Is Up-Regulated in Colorectal Cancer and Regulates Colorectal Cancer Cell Growth and Apoptosis
Zhang, L., Lu, P., Yan, L., Yang, L., Wang, Y., Chen, J., Dai, J., Li, Y., Kang, Z., Bai, T., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.02.003 · Cited by 39
Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer
Bhutia, Y. D., Ogura, J., Grippo, P. J., Torres, C., Sato, T., Wachtel, M. S., Ramachandran, S., Babu, E., Sivaprakasam, S., Rajasekaran, D., et al. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.02.003 · Cited by 38
Mdm2: Open questions
Dobbelstein, M., & Levine, A. J. (2020) · Cancer Science · doi:10.1111/cas.14433 · Cited by 40
Self-citation
In vitro assays for investigating the FLASH effect
Adrian, G., Ruan, J.-L., Paillas, S., Cooper, C. R., & Petersson, K. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.5 · Cited by 38
Impact of hexavalent chromium on mammalian cell bioenergetics: phenotypic changes, molecular basis and potential relevance to chromate-induced lung cancer
Abreu, P. L., Ferreira, L. M. R., Alpoim, M. C., & Urbano, A. M. (2014) · BioMetals · doi:10.1007/s10534-014-9726-7 · Cited by 39
Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro
Hsieh, T. C., Huang, Y., & WU, J. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq230 · Cited by 38
Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing
Sabir, S. H., Krishnamurthy, S., Gupta, S. K., Mills, G. B., Wei, W., Cortés, A., Shaw, K. R. M., Luthra, R., & Wallace, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189651 · Cited by 38
MDM2- an indispensable player in tumorigenesis
Zafar, A., Khan, M. J., & Naeem, A. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08512-3 · Cited by 37
Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview
Nardacci, R., Perfettini, J., Grieco, L., Thieffry, D., Kroemer, G., & Piacentini, M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.204 · Cited by 42
Osteocytes Serve as a Progenitor Cell of Osteosarcoma
Sottnik, J. L., Campbell, B., Mehra, R., Behbahani‐Nejad, O., Hall, C. L., & Keller, E. T. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24793 · Cited by 37
Functional consequences of retro-inverso isomerization of a miniature protein inhibitor of the p53–MDM2 interaction
Li, C., Zhan, C., Zhao, L., Chen, X., Lu, W., & Lu, W. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.039 · Cited by 37
Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy
Guo, X., Hu, F., Zhang, S., Zhao, Q., Zong, C., Ye, F., Guo, S., Zhang, J., Li, R., Wu, M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.011 · Cited by 37
PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function
Keskin, N., Deniz, E., Eryilmaz, J., Ün, M., Batur, T., Erşahin, T., Çetin-Atalay, R., Sakaguchi, S., Ellmeier, W., & Erman, B. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01475-14 · Cited by 39
HACE1 is a potential tumor suppressor in osteosarcoma
El-Naggar, A. M., Clarkson, P. W., Negri, G. L., Turgu, B., Zhang, F., Anglesio, M. S., & Sorensen, P. H. B. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1276-4 · Cited by 37
Sesamin suppresses NSCLC cell proliferation and induces apoptosis via Akt/p53 pathway
Chen, Y., Li, H., Zhang, W., Qi, W., Lu, C., Huang, H., Yang, Z., Liu, B., & Zhang, L. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114848 · Cited by 37
Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review
Fiore, A., Liang, Y., Lin, Y. H., Tung, J., Wang, H., Langlais, D., & Nijnik, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083007 · Cited by 40
Dietary Flavonoids in p53—Mediated Immune Dysfunctions Linking to Cancer Prevention
Siddiqui, S. S., Rahman, S., Rupasinghe, H. P. V., & Vazhappilly, C. G. (2020) · Biomedicines · doi:10.3390/biomedicines8080286 · Cited by 36
The clinical relevance of new insights in iron transport and metabolism.
Brissot, P., Troadec, M., & Loréal, O. (2004) · PubMed · Cited by 36
p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis
Rius‐Pérez, S. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.022 · Cited by 37
Tumor suppressor FOXO3 regulates ribonucleotide reductase subunit RRM2B and impacts on survival of cancer patients
Cho, E.-C., Kuo, M.-L., Liu, X., Yang, L., Hsieh, Y., Wang, J., Cheng, Y., & Yen, Y. (2014) · Oncotarget · doi:10.18632/oncotarget.2044 · Cited by 36
p53, a novel regulator of lipid metabolism pathways
Goldstein, I., Ezra, O., Rivlin, N., Molchadsky, A., Madar, S., Goldfinger, N., & Rotter, V. (2012) · BMC Proceedings · doi:10.1186/1753-6561-6-s3-p61 · Cited by 36
E2 Ubiquitin-conjugating Enzyme, UBE2C Gene, Is Reciprocally Regulated by Wild-type and Gain-of-Function Mutant p53
Bajaj, S., Alam, S. K., Roy, K. S., Datta, A., Nath, S., & Roychoudhury, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731398 · Cited by 35
CK1α ablation in keratinocytes induces p53-dependent, sunburn-protective skin hyperpigmentation
Chang, C., Kuo, C.-J., Ito, T., Su, Y.-Y., Jiang, S., Chiu, M., Lin, Y., Nist, A., Mernberger, M., Stiewe, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702763114 · Cited by 35
Functional Diversity of p53 in Human and Wild Animals
Li, Y., Zhang, M., Xu, X., Zhao, Y., Chatoo, M., Zhu, T., Deng, H., Nevo, E., Du, J.-Z., & Chen, X. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00152 · Cited by 36
The Anticancer Activity and Mechanisms of Ginsenosides: An Updated Review
Chen, H., Yang, H., Fan, D., & Deng, J. (2020) · eFood · doi:10.2991/efood.k.200512.001 · Cited by 37
AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
Yan, B., Claxton, D. F., Huang, S., & Qiu, Y. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.06.003 · Cited by 37
RETRACTED: Targeted immunotherapy for HER2-low breast cancer with 17p loss
Li, Y., Sun, Y., Kulke, M., Hechler, T., der Jeught, K. V., Dong, T., He, B., Miller, K. D., Radovich, M., Schneider, B. P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc6894 · Cited by 37
Retracted
Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases
Mohammed, S., Shamseddine, A. A., Newcomb, B., Chavez, R. S., Panzner, T. D., Lee, A. H., Canals, D., Okeoma, C. M., Clarke, C. J., & Hannun, Y. A. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01452-5 · Cited by 36
TP53 Gain-of-Function and Non–Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma
Pan, M., Jiang, C., Zhang, Z., Achacoso, N. S., Alexeeff, S., Solorzano, A. V., Tse, P., Chung, E. H., Sundaresan, T. K., Suga, J. M., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00570 · Cited by 38
BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models
Hao, X., Bahia, R. K., Cseh, O., Bozek, D. A., Blake, S., Rinnenthal, J., Weyer-Czernilofsky, U., Rudolph, D., & Artee Luchman, H. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noac271 · Cited by 34
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 38
CacyBP/SIP protein is important for the proliferation of human glioma cells
Shi, H., Gao, Y., Tang, Y., Wu, Y., Gong, H., Du, J. T., Zheng, B., Hu, J., Shi, Q., & Yu, R. (2014) · IUBMB Life · doi:10.1002/iub.1263 · Cited by 35
p53: Its Mutations and Their Impact on Transcription
Vaughan, C. A., Pearsall, I., Yeudall, W. A., Deb, S. P., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_4 · Cited by 37
Gender and the regulation of longevity: Implications for autoimmunity
Pan, Z., & Chang, C. C. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.12.004 · Cited by 36
Battle Against Cancer: An Everlasting Saga of p53
Hao, Q., & Cho, W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151222109 · Cited by 38
Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma
Schilling, T., Kairat, A., Melino, G., Krammer, P. H., Stremmel, W., Oren, M., & Müller, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.082 · Cited by 36
Self-citation
Genetic background influences susceptibility to chemotherapy-induced hematotoxicity
Gatti, D. M., Weber, S. N., Goodwin, N. C., Lammert, F., & Churchill, G. A. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2017.23 · Cited by 33
The emerging role of miR‐19 in glioma
Wang, W., Zhang, A., Hao, Y., Wang, G., & Jia, Z. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13788 · Cited by 35
KDM5A Regulates a Translational Program that Controls p53 Protein Expression
Hu, D., Jablonowski, C. M., Cheng, P.-H., AlTahan, A. M., Li, C., Wang, Y., Palmer, L. E., Lan, C., Sun, B., Abu‐Zaid, A., et al. (2018) · iScience · doi:10.1016/j.isci.2018.10.012 · Cited by 34
Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms
Han, A., Li, C., Zahed, T., Wong, M. K., Smith, I. F., Hoedel, K., Green, D. R., & Boiko, A. D. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000402 · Cited by 36
p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
Smirnov, A., Anemona, L., Novelli, F., Piro, M. C., Annicchiarico‐Petruzzelli, M., Melino, G., & Candi, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225781 · Cited by 35

Authors: Levine, A. J., & Oren, M.
Affiliations: Institute for Advanced Study (US)
Weizmann Institute of Science (IL)
ORCID: Levine, Arnold J.
Oren, Moshe
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-10
Volume: 9
Issue: 10
Pages: 749-758
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2723
PMC: PMC2771725
OpenAlex: W1966163762
Cited by: 1,967
References: 169
Citations by year: 2026: 64 · 2025: 111 · 2024: 107 · 2023: 112 · 2022: 114 · 2021: 129 · 2020: 128 · 2019: 111 · 2018: 127 · 2017: 120 · 2016: 144 · 2015: 115 · 2014: 150 · 2013: 113 · 2012: 170
FWCI: 9.34
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P01CA087497, R37 CA40099, R37CA040099, P01CA87497.)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: p53, TP53, tumour suppressor, SV40 large T antigen, transcription factors, cell cycle arrest, apoptosis, cellular senescence, metabolic regulation, cytokine regulation, embryo implantation
MeSH terms: Animals, Humans, Neoplasms, Genes, p53, Tumor Suppressor Protein p53, History, 20th Century, History, 21st Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The first 30 years of p53: growing ever more complex.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks